{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:16Z","timestamp":1791357376879,"version":"4.3.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.psychres.2023.115133","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T14:14:51Z","timestamp":1678025691000},"page":"115133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder"],"prefix":"10.1016","volume":"323","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-9677","authenticated-orcid":false,"given":"Kevork","family":"Danayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Chisamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D. Di","family":"Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-1785","authenticated-orcid":false,"given":"Shakila","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-6061","authenticated-orcid":false,"given":"Farhan","family":"Fancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2928-6711","authenticated-orcid":false,"given":"Aniqa","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kratiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Arekapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-2523","authenticated-orcid":false,"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2023.115133_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2023.115133_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/070674370505000407","article-title":"Major depression in patients with borderline personality disorder: a clinical investigation","volume":"50","author":"Bellino","year":"2005","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0004","article-title":"Comorbidities in borderline personality disorder","volume":"30","author":"Biskin","year":"2013","journal-title":"Psychiatric Times"},{"key":"10.1016\/j.psychres.2023.115133_bib0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1521\/pedi.18.3.226.35445","article-title":"Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention","volume":"18","author":"Black","year":"2004","journal-title":"J. Pers. Disord."},{"key":"10.1016\/j.psychres.2023.115133_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000173701","article-title":"The short version of the Borderline Symptom List (BSL-23): development and initial data on psychometric properties","volume":"42","author":"Bohus","year":"2009","journal-title":"Psychopathology"},{"key":"10.1016\/j.psychres.2023.115133_bib0007","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000098493","article-title":"Psychometric properties of the borderline symptom list (BSL)","volume":"40","author":"Bohus","year":"2007","journal-title":"Psychopathology"},{"key":"10.1016\/j.psychres.2023.115133_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2022.07.054","article-title":"The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder","volume":"315","author":"Chen","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2023.115133_bib0009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.2044-8260.2011.02017.x","article-title":"A real-world study of the effectiveness of DBT in the UK national health service","volume":"51","author":"Feigenbaum","year":"2012","journal-title":"Br. J. Clin. Psychol."},{"key":"10.1016\/j.psychres.2023.115133_bib0010","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1176\/appi.ajp.161.11.2073","article-title":"Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder","volume":"161","author":"Feske","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-023-01540-4","article-title":"A pilot randomized controlled trial of ketamine in borderline personality disorder","author":"Fineberg","year":"2023","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.psychres.2023.115133_bib0012","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000241195","article-title":"Relationship of the borderline symptom list to DSM-IV borderline personality disorder criteria assessed by semi-structured interview","volume":"42","author":"Glenn","year":"2009","journal-title":"Psychopathology"},{"key":"10.1016\/j.psychres.2023.115133_bib0013","doi-asserted-by":"crossref","first-page":"9242","DOI":"10.4088\/JCP.13m08972","article-title":"Interactions of borderline personality disorder and mood disorders over 10 years","volume":"75","author":"Gunderson","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0014","first-page":"1","article-title":"A proposed severity classification of borderline symptoms using the borderline symptom list (BSL-23)","volume":"7","author":"Kleindienst","year":"2020","journal-title":"Borderline Personal Disord. Emot. Dysregul."},{"key":"10.1016\/j.psychres.2023.115133_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.brat.2013.04.008","article-title":"Effectiveness, response, and dropout of dialectical behavior therapy for borderline personality disorder in an inpatient setting","volume":"51","author":"Kr\u00f6ger","year":"2013","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.psychres.2023.115133_bib0016","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","article-title":"Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials","volume":"196","author":"Lieb","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0017","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: results from the Canadian rapid treatment center of excellence","volume":"274","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2023.115133_bib0018","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.2020.20081251","article-title":"Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0019","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/bjp.188.1.13","article-title":"Personality disorder and the outcome of depression: meta-analysis of published studies","volume":"188","author":"Newton-Howes","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0021","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000338897","article-title":"Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial","volume":"81","author":"Priebe","year":"2012","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.psychres.2023.115133_bib0022","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.apnu.2018.02.009","article-title":"Outcomes of dialectical behavior therapy administered by an interdisciplinary team","volume":"32","author":"Robinson","year":"2018","journal-title":"Arch. Psychiatr. Nurs."},{"key":"10.1016\/j.psychres.2023.115133_bib0023","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jad.2020.12.119","article-title":"A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions","volume":"282","author":"Rodrigues","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2023.115133_bib0024","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.psc.2018.07.009","article-title":"Comorbidity of borderline personality disorder: current status and future directions","volume":"41","author":"Shah","year":"2018","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.psychres.2023.115133_bib0025","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v68n0811","article-title":"Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression","volume":"68","author":"Simon","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0026","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-13-139","article-title":"Validation of the Spanish version of the borderline symptom list, short form (BSL-23)","volume":"13","author":"Soler","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-020-01164-1","article-title":"Pharmacotherapy for borderline personality disorder: an update of published, unpublished and ongoing studies","volume":"22","author":"Stoffers-Winterling","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2023.115133_bib0029","article-title":"Pharmacological interventions for borderline personality disorder","volume":"6","author":"Stoffers","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2023.115133_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/HRP.0000000000000045","article-title":"Depression in patients with borderline personality disorder","volume":"22","author":"Yoshimatsu","year":"2014","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115133_bib0031","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1521\/pedi.17.6.568.25355","article-title":"A screening measure for BPD: The McLean screening instrument for borderline personality disorder (MSI-BPD)","volume":"17","author":"Zanarini","year":"2003","journal-title":"J. Pers. Disord."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:57:49Z","timestamp":1759039069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":31,"alternative-id":["S0165178123000847"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115133","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115133"}}